ETFChannel.com
PRPH Description — ProPhase Labs Inc

ProPhase Labs is a company focused on diagnostic and genomic products and services, the development and commercialization of novel drugs, dietary supplements, and compounds, and contract manufacturing. Co. has identified two operating segments. The diagnostic services segment provides SARS-CoV-2 diagnostic information services to a range of customers in the U.S., including health plans, third party payers and government organizations. The consumer products segment is engaged in the research, development, manufacture, distribution, marketing and sale of over-the-counter consumer healthcare products and dietary supplements in the U.S. and also provides personal genomics products and services.

Company Name: 
ProPhase Labs Inc
Website: 
www.ProPhaseLabs.com
Sector: 
Drugs & Pharmaceuticals
Number of ETFs Holding PRPH: 
3
Total Market Value Held by ETFs: 
$3,201,650
Total Market Capitalization: 
$91,000,000
% of Market Cap. Held by ETFs: 
3.52%
 ETF   PRPH Weight   PRPH Amount 
 VTI   0.00%   $2,133,226         
 VXF   0.00%   $926,908         
 IWC   0.02%   $141,516         
Quotes delayed 20 minutes

Email EnvelopeFree PRPH Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts

Strong Buy (4.00 out of 4)
100th percentile
(ranked higher than approx. 100% of all stocks covered)
Based on data provided by Zacks Investment Research via Quandl.com

ETFs Holding PRPH | ProPhase Labs Inc | ETF Channel | www.ETFChannel.com

Copyright © 2010 - 2024, All Rights Reserved Nothing in ETF Channel is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and ETF videos powered by Market News Video. Quote data delayed at least 20 minutes; data powered by Ticker Technologies, and Mergent. Contact ETF Channel; Meet Our Editorial Staff.